

The global Liquid Biopsy Services market size was valued at USD 1670 million in 2023 and is forecast to a readjusted size of USD 7536.5 million by 2030 with a CAGR of 24.0% during review period.
Liquid Biopsy Services refer to the specialized diagnostic services provided by medical laboratories or companies that offer testing and analysis of biomarkers in bodily fluids for disease detection and monitoring.
The publisher report includes an overview of the development of the Liquid Biopsy Services industry chain, the market status of Hospital (CTC Detection, ctDNA Detection), Third-party Testing Agency (CTC Detection, ctDNA Detection), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Liquid Biopsy Services.
Regionally, the report analyzes the Liquid Biopsy Services markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Liquid Biopsy Services market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Liquid Biopsy Services market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Liquid Biopsy Services industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., CTC Detection, ctDNA Detection).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Liquid Biopsy Services market.
Regional Analysis: The report involves examining the Liquid Biopsy Services market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Liquid Biopsy Services market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Liquid Biopsy Services:
Company Analysis: Report covers individual Liquid Biopsy Services players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Liquid Biopsy Services This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Third-party Testing Agency).
Technology Analysis: Report covers specific technologies relevant to Liquid Biopsy Services. It assesses the current state, advancements, and potential future developments in Liquid Biopsy Services areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Liquid Biopsy Services market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Liquid Biopsy Services market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
CTC Detection
ctDNA Detection
Exosome Detection
Market segment by Application
Hospital
Third-party Testing Agency
Market segment by players, this report covers
Bio-Rad
Roche
Biocartis
Qiagen
Guardant Health
MDxHealth
OME Care
NeoGenomics Laboraories
Sysmex Inostics
Menarini Silicon Biosystems
Adaptive Biotechnologies
Biocept
Angle plc
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Liquid Biopsy Services product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Liquid Biopsy Services, with revenue, gross margin and global market share of Liquid Biopsy Services from 2019 to 2024.
Chapter 3, the Liquid Biopsy Services competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Liquid Biopsy Services market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Liquid Biopsy Services.
Chapter 13, to describe Liquid Biopsy Services research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Market Overview
1.1 Product Overview and Scope of Liquid Biopsy Services
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Liquid Biopsy Services by Type
1.3.1 Overview: Global Liquid Biopsy Services Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Liquid Biopsy Services Consumption Value Market Share by Type in 2023
1.3.3 CTC Detection
1.3.4 ctDNA Detection
1.3.5 Exosome Detection
1.4 Global Liquid Biopsy Services Market by Application
1.4.1 Overview: Global Liquid Biopsy Services Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Third-party Testing Agency
1.5 Global Liquid Biopsy Services Market Size & Forecast
1.6 Global Liquid Biopsy Services Market Size and Forecast by Region
1.6.1 Global Liquid Biopsy Services Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Liquid Biopsy Services Market Size by Region, (2019-2030)
1.6.3 North America Liquid Biopsy Services Market Size and Prospect (2019-2030)
1.6.4 Europe Liquid Biopsy Services Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Liquid Biopsy Services Market Size and Prospect (2019-2030)
1.6.6 South America Liquid Biopsy Services Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Liquid Biopsy Services Market Size and Prospect (2019-2030)
2 Company Profiles
2.1 Bio-Rad
2.1.1 Bio-Rad Details
2.1.2 Bio-Rad Major Business
2.1.3 Bio-Rad Liquid Biopsy Services Product and Solutions
2.1.4 Bio-Rad Liquid Biopsy Services Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Bio-Rad Recent Developments and Future Plans
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business
2.2.3 Roche Liquid Biopsy Services Product and Solutions
2.2.4 Roche Liquid Biopsy Services Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Roche Recent Developments and Future Plans
2.3 Biocartis
2.3.1 Biocartis Details
2.3.2 Biocartis Major Business
2.3.3 Biocartis Liquid Biopsy Services Product and Solutions
2.3.4 Biocartis Liquid Biopsy Services Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Biocartis Recent Developments and Future Plans
2.4 Qiagen
2.4.1 Qiagen Details
2.4.2 Qiagen Major Business
2.4.3 Qiagen Liquid Biopsy Services Product and Solutions
2.4.4 Qiagen Liquid Biopsy Services Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Qiagen Recent Developments and Future Plans
2.5 Guardant Health
2.5.1 Guardant Health Details
2.5.2 Guardant Health Major Business
2.5.3 Guardant Health Liquid Biopsy Services Product and Solutions
2.5.4 Guardant Health Liquid Biopsy Services Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Guardant Health Recent Developments and Future Plans
2.6 MDxHealth
2.6.1 MDxHealth Details
2.6.2 MDxHealth Major Business
2.6.3 MDxHealth Liquid Biopsy Services Product and Solutions
2.6.4 MDxHealth Liquid Biopsy Services Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 MDxHealth Recent Developments and Future Plans
2.7 OME Care
2.7.1 OME Care Details
2.7.2 OME Care Major Business
2.7.3 OME Care Liquid Biopsy Services Product and Solutions
2.7.4 OME Care Liquid Biopsy Services Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 OME Care Recent Developments and Future Plans
2.8 NeoGenomics Laboraories
2.8.1 NeoGenomics Laboraories Details
2.8.2 NeoGenomics Laboraories Major Business
2.8.3 NeoGenomics Laboraories Liquid Biopsy Services Product and Solutions
2.8.4 NeoGenomics Laboraories Liquid Biopsy Services Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 NeoGenomics Laboraories Recent Developments and Future Plans
2.9 Sysmex Inostics
2.9.1 Sysmex Inostics Details
2.9.2 Sysmex Inostics Major Business
2.9.3 Sysmex Inostics Liquid Biopsy Services Product and Solutions
2.9.4 Sysmex Inostics Liquid Biopsy Services Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Sysmex Inostics Recent Developments and Future Plans
2.10 Menarini Silicon Biosystems
2.10.1 Menarini Silicon Biosystems Details
2.10.2 Menarini Silicon Biosystems Major Business
2.10.3 Menarini Silicon Biosystems Liquid Biopsy Services Product and Solutions
2.10.4 Menarini Silicon Biosystems Liquid Biopsy Services Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Menarini Silicon Biosystems Recent Developments and Future Plans
2.11 Adaptive Biotechnologies
2.11.1 Adaptive Biotechnologies Details
2.11.2 Adaptive Biotechnologies Major Business
2.11.3 Adaptive Biotechnologies Liquid Biopsy Services Product and Solutions
2.11.4 Adaptive Biotechnologies Liquid Biopsy Services Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Adaptive Biotechnologies Recent Developments and Future Plans
2.12 Biocept
2.12.1 Biocept Details
2.12.2 Biocept Major Business
2.12.3 Biocept Liquid Biopsy Services Product and Solutions
2.12.4 Biocept Liquid Biopsy Services Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Biocept Recent Developments and Future Plans
2.13 Angle plc
2.13.1 Angle plc Details
2.13.2 Angle plc Major Business
2.13.3 Angle plc Liquid Biopsy Services Product and Solutions
2.13.4 Angle plc Liquid Biopsy Services Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Angle plc Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Liquid Biopsy Services Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Liquid Biopsy Services by Company Revenue
3.2.2 Top 3 Liquid Biopsy Services Players Market Share in 2023
3.2.3 Top 6 Liquid Biopsy Services Players Market Share in 2023
3.3 Liquid Biopsy Services Market: Overall Company Footprint Analysis
3.3.1 Liquid Biopsy Services Market: Region Footprint
3.3.2 Liquid Biopsy Services Market: Company Product Type Footprint
3.3.3 Liquid Biopsy Services Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Liquid Biopsy Services Consumption Value and Market Share by Type (2019-2024)
4.2 Global Liquid Biopsy Services Market Forecast by Type (2025-2030)
5 Market Size Segment by Application
5.1 Global Liquid Biopsy Services Consumption Value Market Share by Application (2019-2024)
5.2 Global Liquid Biopsy Services Market Forecast by Application (2025-2030)
6 North America
6.1 North America Liquid Biopsy Services Consumption Value by Type (2019-2030)
6.2 North America Liquid Biopsy Services Consumption Value by Application (2019-2030)
6.3 North America Liquid Biopsy Services Market Size by Country
6.3.1 North America Liquid Biopsy Services Consumption Value by Country (2019-2030)
6.3.2 United States Liquid Biopsy Services Market Size and Forecast (2019-2030)
6.3.3 Canada Liquid Biopsy Services Market Size and Forecast (2019-2030)
6.3.4 Mexico Liquid Biopsy Services Market Size and Forecast (2019-2030)
7 Europe
7.1 Europe Liquid Biopsy Services Consumption Value by Type (2019-2030)
7.2 Europe Liquid Biopsy Services Consumption Value by Application (2019-2030)
7.3 Europe Liquid Biopsy Services Market Size by Country
7.3.1 Europe Liquid Biopsy Services Consumption Value by Country (2019-2030)
7.3.2 Germany Liquid Biopsy Services Market Size and Forecast (2019-2030)
7.3.3 France Liquid Biopsy Services Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Liquid Biopsy Services Market Size and Forecast (2019-2030)
7.3.5 Russia Liquid Biopsy Services Market Size and Forecast (2019-2030)
7.3.6 Italy Liquid Biopsy Services Market Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Liquid Biopsy Services Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Liquid Biopsy Services Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Liquid Biopsy Services Market Size by Region
8.3.1 Asia-Pacific Liquid Biopsy Services Consumption Value by Region (2019-2030)
8.3.2 China Liquid Biopsy Services Market Size and Forecast (2019-2030)
8.3.3 Japan Liquid Biopsy Services Market Size and Forecast (2019-2030)
8.3.4 South Korea Liquid Biopsy Services Market Size and Forecast (2019-2030)
8.3.5 India Liquid Biopsy Services Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Liquid Biopsy Services Market Size and Forecast (2019-2030)
8.3.7 Australia Liquid Biopsy Services Market Size and Forecast (2019-2030)
9 South America
9.1 South America Liquid Biopsy Services Consumption Value by Type (2019-2030)
9.2 South America Liquid Biopsy Services Consumption Value by Application (2019-2030)
9.3 South America Liquid Biopsy Services Market Size by Country
9.3.1 South America Liquid Biopsy Services Consumption Value by Country (2019-2030)
9.3.2 Brazil Liquid Biopsy Services Market Size and Forecast (2019-2030)
9.3.3 Argentina Liquid Biopsy Services Market Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Liquid Biopsy Services Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Liquid Biopsy Services Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Liquid Biopsy Services Market Size by Country
10.3.1 Middle East & Africa Liquid Biopsy Services Consumption Value by Country (2019-2030)
10.3.2 Turkey Liquid Biopsy Services Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Liquid Biopsy Services Market Size and Forecast (2019-2030)
10.3.4 UAE Liquid Biopsy Services Market Size and Forecast (2019-2030)
11 Market Dynamics
11.1 Liquid Biopsy Services Market Drivers
11.2 Liquid Biopsy Services Market Restraints
11.3 Liquid Biopsy Services Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Liquid Biopsy Services Industry Chain
12.2 Liquid Biopsy Services Upstream Analysis
12.3 Liquid Biopsy Services Midstream Analysis
12.4 Liquid Biopsy Services Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Bio-Rad
Roche
Biocartis
Qiagen
Guardant Health
MDxHealth
OME Care
NeoGenomics Laboraories
Sysmex Inostics
Menarini Silicon Biosystems
Adaptive Biotechnologies
Biocept
Angle plc
Ìý
Ìý
*If Applicable.